Xenon (XENE)
NASDAQ:XENE

Xenon (XENE) Stock Price & Analysis

199 Followers

XENE Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$24.94 - $41.39
Previous Close$39.19
Volume30.66K
Average Volume (3M)384.43K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$638.18M
Total Debt (Recent Filing)$7.16M
Price to Earnings (P/E)-20.0
Beta1.11
Next EarningsMar 08, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)-1.96
Shares Outstanding62,544,019
R-Squared0.11
Standard Deviation0.21
10 Day Avg. Volume307,208
30 Day Avg. Volume384,433
Price to Book (P/B)3.25
Price to Sales (P/S)259.75
Price to Cash Flow (P/CF)197.40
P/FCF Ratio-36.60
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside28.99% Upside
Rating ConsensusStrong Buy
Alpha0.05
Number of Analyst Covering9


Financials

Annual

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

XENE FAQ

What was Xenon’s price range in the past 12 months?
Xenon lowest stock price was $24.94 and its highest was $41.39 in the past 12 months.
    What is Xenon’s market cap?
    Currently, no data Available
    When is Xenon’s upcoming earnings report date?
    Xenon’s upcoming earnings report date is Mar 08, 2023 which is in 30 days.
      How were Xenon’s earnings last quarter?
      Xenon released its earnings results on Nov 08, 2022. The company reported -$0.57 earnings per share for the quarter, missing the consensus estimate of -$0.52 by -$0.05.
        Is Xenon overvalued?
        According to Wall Street analysts Xenon’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Xenon pay dividends?
          Xenon does not currently pay dividends.
          What is Xenon’s EPS estimate?
          Xenon’s EPS estimate is -$0.59.
            How many shares outstanding does Xenon have?
            Xenon has 62,544,018 shares outstanding.
              What happened to Xenon’s price movement after its last earnings report?
              Xenon reported an EPS of -$0.57 in its last earnings report, missing expectations of -$0.52. Following the earnings report the stock price went down -6.61%.
                Which hedge fund is a major shareholder of Xenon?
                Among the largest hedge funds holding Xenon’s share is Driehaus Capital Management LLC. It holds Xenon’s shares valued at 163M.

                  ---

                  Xenon Stock Smart Score

                  The Xenon stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Xenon

                  Xenon Pharmaceuticals, Inc. engages in discovering and developing therapeutics to improve the lives of patients with neurological disorders. It focuses on the treatment of epilepsy. Its products include XEN496, XEN1101, XEN901, and XEN007. The company was founded by Simon Neil Pimstone, Johannes J. P. Kastelein, and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.

                  ---

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Aurinia Pharmaceuticals
                  Repare Therapeutics
                  Zymeworks
                  Sernova

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis